Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”

1. Schneller-Pavelescu, L.
2. Vergara-de Caso, E.
3. Martorell, A.
4. Romaní, J.
5. Lázaro, M.
6. Vilarrasa, E.
7. Díaz-Ley, B.
8. Vázquez-Osorio, I.
9. Segura Palacios, J.M.
10. Azaña, J.M.
11. González-López, M.A.
12. Cañueto, J.
13. Molina-Leyva, A.
14. Leiva-Salinas, M.
15. Navarro-Triviño, F.J.
16. Sánchez-Payá, J.
17. Pascual, J.C.